TY  - JOUR
AU  - Merino Almazan, Macarena
AU  - Marin Pozo, Juan Francisco
AU  - Duarte Perez, Juan Manuel
PY  - 2021
DO  - 10.31925/farmacia.2021.3.4
SN  - 0014-8237
UR  - http://hdl.handle.net/10668/19495
T2  - Farmacia
AB  - Chemotherapy agents such as docetaxel are still used after failure of first or second-line immunotherapy. In order to establish the ideal choice of treatment, it is necessary to compare the efficacy and safety in the real-world setting between the...
LA  - en
PB  - Soc stiinte farmaceutice romania
KW  - docetaxel
KW  - non-small cell lung cancer
KW  - real-world data
KW  - nintedanib
KW  - Nintedanib
KW  - Nivolumab
KW  - Phase-3
TI  - EVALUATION OF DOCETAXEL USE IN NON-SMALL CELL LUNG CANCER: REAL-WORLD HEALTH OUTCOMES
TY  - research article
VL  - 69
ER  -